Haberler & Etkinlikler
OMRON Healthcare presents Nami Cat, a nebuliser designed to appeal to young children
OMRON Healthcare presents Nami Cat, a nebuliser designed to appeal to young children Hoofddorp, The Netherlands. OMRON Healthcare Europe -a global leader in medical equipment for home health monitoring and therapy- presents Nami Cat, a joyful nebuliser designed to appeal to young children while delivering high-quality treatment. This child-friendly design resembles a cat, and so …
OMRON Healthcare presents Nami Cat, a nebuliser designed to appeal to young children
Hoofddorp, The Netherlands. OMRON Healthcare Europe -a global leader in medical equipment for home health monitoring and therapy- presents Nami Cat, a joyful nebuliser designed to appeal to young children while delivering high-quality treatment. This child-friendly design resembles a cat, and so it helps children to enjoy a more comfortable nebulising experience and enables the adoption of nebulising treatment from an early age.
“As part of our Zero Asthma Attack strategy, we knew that young children might find traditional nebulisers somewhat scary, leading them to refuse treatment right when they need it the most. With this in mind, we put our effort into finding a solution that allowed parents to provide a more seamless nebulising experience for their little ones, and make a habit of nebulising from a very early age. Nami Cat provides a relaxing experience and ensures OMRON Healthcare’s respiratory solutions high quality”, said Lucia Prada, Marketing Director of OMRON Healthcare Europe.
OMRON Healthcare has a proven track record in developing innovations to provide more efficient respiratory treatment for children, who are among the primary nebuliser users in the household. Products like C102 Total and DuoBaby are equipped with special features to keep a child’s nose clean and combat runny or blocked noses the whole year round, and the MicroAir U100’s groundbreaking mesh technology allows the little ones to get nebulising treatment in any position. Nami Cat is the latest stop in this ongoing innovation journey, helping children accept treatment by bringing the playful aspect to nebulisation to the forefront.
Nami Cat offers efficient nebulising to effectively treat a wide range of respiratory conditions that vary from a simple cough to bronchitis and asthma, at a nebulization rate of 0.35 ml/min. The cat design was decided based on a test conducted by OMRON Healthcare Europe. Its results showed that the cat concept was the most appealing to children.
About OMRON Healthcare Europe
Committed to helping people live more active and fulfilling lives with zero compromise, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for health monitoring and therapy.
Throughout its 85-year history OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat and manage their medical conditions, both at home and in clinical practice in over 117 countries.
OMRON Healthcare is the No. 1 brand recommended by cardiologists in Europe for blood pressure monitors and the Global No. 1 brand in nebulisers for respiratory treatment with over 30 million devices sold. The company’s additional core product categories are low-frequency pain therapy equipment, body composition monitors and electronic thermometers.
OMRON Healthcare Group is headquartered in Kyoto, Japan. OMRON Healthcare Europe B.V. is the healthcare division for Europe, Russia, Middle East and Africa and provides services to customers in more than 74 countries.
OMRON Healthcare Europe B.V.
Scorpius 33, 2132 LR Hoofddorp, The Netherlands
+31 (0)23 55 44 700, info.omronhealthcare@eu.omron.com